Trial Profile
A Retrospective Study Comparing Clinical Outcomes of Dapagliflozin plus Metformin or Glipizide plus Metformin Using Noninterventional U.S Electronic Medical Record (EMR) Data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Glipizide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 17 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.